Antisense oligonucleotides with different backbones - Modification of splicing pathways and efficacy of uptake

被引:81
|
作者
Schmajuk, G
Sierakowska, H
Kole, R
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.274.31.21783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel, positive read-out assay that quantifies only sequence-specific nuclear activity of antisense oligonucleotides was used to evaluate morpholino and 2'-O-methyl sugar-phosphate oligonucleotides. The assay is based on modification of the splicing pathway of human beta-globin pre-mRNA, In addition, scrape-loading of cells with oligonucleotides allows the separate assessment of intracellular antisense activity of the oligonucleotides and their ability to penetrate the cell membrane barrier. The results show that, with scrape-loading, the morpholino oligonucleotides were approximately 3-fold more effective in their intrinsic antisense activity than alternating phosphodiester/phosphorothioate 2'-O-methyl-oligoribonucleotides and 6-9- and almost 200-fold more effective than the exclusively phosphorothioate and phosphodiester derivatives, respectively. The morpholino oligonucleotides were over 20-fold more effective than the phosphorothioate 2'-O-methyl-oligoribonucleotides in free uptake from the culture media. The antisense activity of the morpholino oligonucleotides was detectable not only in monolayer HeLa cells but also in suspension K562 cells. Time course experiments suggest that both the free uptake and efflux of morpholino oligonucleotides are slow.
引用
收藏
页码:21783 / 21789
页数:7
相关论文
共 50 条
  • [1] Modification of splicing pathways by antisense oligonucleotides.
    Kole, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U237 - U237
  • [2] Modification of pre-mRNA splicing by antisense oligonucleotides
    Kole, R
    ACTA BIOCHIMICA POLONICA, 1997, 44 (02) : 231 - 237
  • [3] COMPARISON OF RIGID AND FLEXIBLE BACKBONES IN ANTISENSE OLIGONUCLEOTIDES
    DEMESMAEKER, A
    WALDNER, A
    SANGHVI, YS
    LEBRETON, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (03) : 395 - 398
  • [4] Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases
    Mercatante, D. R.
    Sazani, P.
    Kole, R.
    CURRENT CANCER DRUG TARGETS, 2001, 1 (03) : 211 - 230
  • [5] Nuclear targeting of antisense oligonucleotides: Modification of pre-mRNA splicing or inhibition of polyadenylation?
    Tomasi, V
    Spisni, E
    Griffoni, C
    Santi, S
    NUCLEOSIDES & NUCLEOTIDES, 1998, 17 (9-11): : 2073 - 2080
  • [6] Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy
    Leonetti, C.
    Zupi, G.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (05) : 463 - 470
  • [7] Modification of antisense, oligonucleotides and the second generation antisense drugs
    Chen, Xiaolan
    Wei, Dongzhi
    Yuan, Qinsheng
    Zhongguo Yaoxue Zazhi/Chinese Pharmaceutical Journal, 1999, 34 (02):
  • [8] Cellular uptake and trafficking of antisense oligonucleotides
    Stanley T Crooke
    Shiyu Wang
    Timothy A Vickers
    Wen Shen
    Xue-hai Liang
    Nature Biotechnology, 2017, 35 : 230 - 237
  • [9] Cellular uptake and trafficking of antisense oligonucleotides
    Crooke, Stanley T.
    Wang, Shiyu
    Vickers, Timothy A.
    Shen, Wen
    Liang, Xue-hai
    NATURE BIOTECHNOLOGY, 2017, 35 (03) : 230 - 237
  • [10] Minimal modification of antisense oligonucleotides.
    Uhlmann, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U220 - U220